Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to their highly invasive nature and relatively low response to therapeutics. There is an absence of specific treatment strate...

Full description

Bibliographic Details
Main Authors: Mauricio A. Medina, Goldie Oza, Ashutosh Sharma, L.G. Arriaga, José Manuel Hernández Hernández, Vincent M. Rotello, Jose Tapia Ramirez
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:International Journal of Environmental Research and Public Health
Subjects:
nanomedicine
triple negative breast cancer
artificial intelligence
theranostics
immunotherapy
Online Access:https://www.mdpi.com/1660-4601/17/6/2078

Internet

https://www.mdpi.com/1660-4601/17/6/2078

Similar Items